Laman Utama084990 • KOSDAQ
add
Helixmith Co Ltd
Tutup sebelumnya
₩2,650.00
Julat hari
₩2,650.00 - ₩2,795.00
Julat tahun
₩2,115.00 - ₩4,950.00
Permodalan pasaran
127.45B KRW
Bilangan Purata
98.93K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
KOSDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(KRW) | Dis 2024info | Perubahan T/T |
---|---|---|
Hasil | 1.63B | 203.14% |
Perbelanjaan pengendalian | 2.28B | -65.70% |
Pendapatan bersih | -1.96B | 94.61% |
Margin untung bersih | -120.28 | 98.22% |
Pendapatan bagi setiap syer | — | — |
EBITDA | -280.49J | 92.01% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(KRW) | Dis 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 76.11B | -33.22% |
Jumlah aset | 148.89B | -34.49% |
Jumlah liabiliti | 6.85B | -90.68% |
Jumlah ekuiti | 142.04B | — |
Syer tertunggak | 46.05J | — |
Harga kepada buku | 0.86 | — |
Pulangan pada aset | -2.10% | — |
Pulangan pada modal | -2.19% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(KRW) | Dis 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -1.96B | 94.61% |
Tunai daripada operasi | -1.39B | 68.41% |
Tunai daripada pelaburan | 1.38B | 111.33% |
Tunai daripada pembiayaan | -5.47J | -100.02% |
Perubahan bersih dalam tunai | -363.50J | -101.86% |
Aliran tunai bebas | -2.04B | -104.61% |
Perihal
Helixmith Co. LTD. is a biotechnology company located in Seoul, South Korea with US presence in San Diego. The company has an extensive gene therapy pipeline, including a non-viral plasmid DNA program for neuromuscular and ischemic disease, a CAR-T program targeting several different types of solid tumors, and an AAV vector program targeting neuromuscular diseases. Helixmith’s lead gene is Engensis, currently in phase III diabetic peripheral neuropathy in the US. Engensis is a plasmid DNA designed to simultaneously express two isoforms of hepatocyte growth factor, HGF 728 and HGF 723. In addition to DPN, Engensis is also being studied in diabetic foot ulcers, amyotrophic lateral sclerosis, coronary artery disease, claudication, and Charcot-Marie-Tooth disease. Wikipedia
Diasaskan
Nov 1996
Tapak web
Pekerja
72